delphinidin has been researched along with Cholangiocellular Carcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, L; Fu, X; Li, H; Liu, S; Qin, J; Tan, L; Wang, H; Wu, M | 1 |
1 other study(ies) available for delphinidin and Cholangiocellular Carcinoma
| Article | Year |
|---|---|
A novel diagnostic marker, p28GANK distinguishes hepatocellular carcinoma from potential mimics.
Topics: alpha-Fetoproteins; Biomarkers, Tumor; Carcinoma, Hepatocellular; Cholangiocarcinoma; Diagnosis, Differential; Hepatocytes; Humans; Immunohistochemistry; Keratins; Liver Neoplasms; Oncogene Proteins; Paraffin; Proteasome Endopeptidase Complex; Proto-Oncogene Proteins; Sensitivity and Specificity | 2004 |